Mon. 6 May 2024, 4:35pm ET
Benzinga
Earnings, Earnings Misses, News
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.77) by 1.3 percent. This is a 16.42 percent decrease over losses of $(0.67) per share from the same period last year.